NARCOLEPSY: PROBLEMS OF DIAGNOSIS AND TREATMENT

1 Parkes D. Excessive daytime sleepiness. Proc R Coll Physicians Edinb 2001; 31:50.

2 Ohayon MM RG Priest Caulet M Hypnagogic and hypnopompic hallucinations: pathological phenomena? Br J Psychiatry 1996; 169:459–67.

3 Billiard M. Narcolepsies. Rev Prat 1996; 46:2428–34.

4 Stores G. Recognition and management of narcolepsy. Arch Dis Child 1999; 81:519–24.

5 Kotagal S. Narcolepsy in children. Semin Pediatr Neurol 1996; 3: 36–43.

6 Kotagal S. Sleep disorders in school-age children. Indian J Pediatr 1997; 64:625–38.

7 Parkes JD SY Chen Clift SJ The clinical diagnosis of the narcoleptic syndrome. J Sleep Res 1998; 7:41–52.

8 Aird RB NS Gordon Gregg HC. Use of phenacemide (phenurone) in treatment of narcolepsy and cataplexy. A preliminary report. Arch Neurol Psychiat 1953; 70:510–15.

9 Guilleminault C Pelayo R. Narcolepsy in children. A practical guide to its diagnosis, treatment and follow-up. Paediatr Drugs 2000; 2:1–9.

10 Dahl RE. The development and disorders of sleep. Adv Pediatr 1998; 45:73–90.

11 Guilleminault C Pelayo R. Narcolepsy in prepubertal children. Ann Neurol 1998; 43:135–42.

12 Lenti C Somajni F. Narcolepsy in an 8-year-old boy: neurologic psychiatric study. J Child Neurol 1998; 13:405–7.

13 MacFarlane JG SJ List Moldofsky H Dopamine D2 receptors quantified in vivo in human narcolepsy. Biol Psychiatry1997; 41:305–10.

14 Sandyk R. Melatonin and maturation of REM sleep. Int J Neurosci 1992; 63:105–14.

15 Nishino S B Ripley Overeem S Hypicretin (orexin) deficiency in human narcolepsy. Lancet 2000; 355:39–40.

16 Siegel JM. Narcolepsy: a key role for hypocretins (orexins). Cell 1999; 98:409–12.

17 Mignot E M Tafti Dement WC Narcolepsy and immunity. Adv Neuroimmunol 1995; 5:23–37.

18 Schuld A J Hebebrand Geller F Increased body-mass index in patients with narcolepsy. Lancet 2000; 355:1274–5.

19 Genton P K Benlakhel Disdier P Diagnostic de la narcolepsie-cataplexie: intérêt de l’enregistrement continu sous EEG ambulatoire. À propos de observations. Neurophysiol Clin 1995; 25:187–95.

20 Folkerts M L Rosenthal Roehrs T The reliability of the diagnostic features in patients with narcolepsy. Biol Psychiatry 1996; 40:208–14.

21 Dyken ME T Yamada Lin-Dyken DC Diagnosing narcolepsy through the simultaneous clinical and electrophysiologic analysis of cataplexy. Arch Neurol 1996; 53:456–60.

22Wing Y-K, Chen C-N, CKW Ho. HLA DR2 and DQ1 frequency among narcoleptic patients in Hong Kong Chinese. Psychiatry Clin Neurosci 1998; 52:523–7.

23Mignot, E, Hayduk R, Black J HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep 1997; 20:1012–20.

24 Planelles D N Puig Beneto A HLA-DQA, -DQB and -DRB allele contribution to narcolepsy susceptibility. Eur J Immunogenet 1997; 24:409–21.

25 Nevšímalová S E Mignot Šonka K Familial aspects of narcolepsy-cataplexy in the Czech Republic. Sleep 1997; 20:1021–6.

26 Aldrich MS. The clinical spectrum of narcolepsy and idiopathic hypersomnia. Neurology 1996; 46:393–401.

27 Vgontzas AN EO Bixler Kales A Daytime sleepiness and REM abnormalities in Prader-Willi syndrome: evidence of generalized hypoarousal. Int J Neurosci 1996; 87:127–39.

28 Scharf MB AA Lai Branigan B Pharmacokinetics of gammahydroxybuterate (GHB) in narcoleptic patients. Sleep 1998; 21:507–14.

29 Richdale AL S Cotton Sleep Hibbit K. disturbance behaviour in Prader-Willi syndrome: a questionnaire study. J Intellect Disabil Res 1999; 43:380–92.

30 Zeman A N Douglas Aylward R. Narcolepsy mistaken for epilepsy. BMJ 2001; 322:216–7.

31 Billiard M C Merle Carlander B Idiopathic hypersomnia. Psychiatry Clinl Neurosci 1998; 52:125–9.

32 Schenck CH KL Boyd A parasomnia overlap disorder involving sleepwalking Mahowald MW. terrors sleep and REM sleep behaviour disorder in 33 polysomnographically confirmed cases. Sleep 1997; 20:972–81.

33 Ellis CM A Simmons Lemmens G Proton spectroscopy in the narcoleptic syndrome. Neurology 1998; 50(Suppl 1):S23–S26.

34US Modafinil in Narcolepsy Multicenter Study Group Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. Ann Neurol 1998; 43:88–97.

35US Modafinil in Narcolepsy Multicenter Study Group Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy. Neurology 2000; 54:1166–75.

36 Ellis CM C Monk Simmons A Functional magnetic resonance imaging neuroactivation studies in normal subjects and subjects with the narcoleptic syndrome. Action of modafinil. J Sleep Res 1999; 8:85–93.

37 Besset A M Chetrit Carlander B Use of modafinil in the treatment of narcolepsy: a long term follow-up study. Neurophysiol Clin 1996; 26:60–6.

38 Broughton RJ FAE Fleming George CFP Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy. Neurology 1997; 49:444–51.

39 Brun J G Chamba Khalfallah Y Effect of modafinil on plasma melatonin, cortisol and growth hormone rhythms, rectal temperature and performance in healthy subjects during a 36 h sleep deprivation. J Sleep Res 1998; 7:105–14.

40 Singh P S Boniello Liu P Transdermal iontophoretic delivery of methylphenidate HCL in vitro. Int J Pharm 1999; 178:121–8.

41 Howe AM. Methamphetamine and childhood and adolescent caries (letter). Aust Dent J 1995; 40:340.

42 Mayer G K Ewert Meier Hephata K. Selegeline hydrochloride treatment in narcolepsy. A double-blind, placebo-controlled study. Clin Pharmocol 1995; 18:306–19.

43 Gordon N. The therapeutics of melatonin: a paediatric perspective. Brain Dev 2000; 22:213–7.

44 Rogers AE MS Aldrich Berrios AM Compliance with stimulant medications in patients with narcolepsy. Sleep 1997; 20:29–33.

45 Garma L Marchand F. Non-pharmacological approaches to the treatment of narcolepsy. Sleep 1994; 17(Suppl 8):S97– S102.

46 Wise MS. Childhood narcolepsy. Neurology 1998; 50(Suppl 1):S37–S42.

47 Heier MS. Narkolepsi hos barn-en dioagnostisk og terapeutisk utfordring. Tidsskr Nor Loegeforen 1998; 19:2961–3.

48 Guilleminault C Brooks SN. Excessive daytime sleepiness. A challenge for the practising neurologist. Brain 2001; 124:1482–8.